fda drug safety communication semaglutide naion 2025 Semaglutide and Non-arteritic Anterior Ischemic Optic Neuropathy: A Systematic Review

Can Ozempic cause vision loss? A study published in JAMA Ophthalmology found that people taking semaglutide (like Ozempic or Wegovy) had a significantly higher risk of developing an eye condition called NAION,

26.39

★★★★☆4.8 (126)

FDA warns consumers not to use counterfeit Ozempic (semaglutide) found in the U.S. drug supply chain. The agency recently seized dozens of units of counterfeit Ozempic (semaglutide) injection 1 mg that were

23.66

★★★★★4.9 (98)

September 8, 2025: FDA launches an import alert listing safe GLP-1 manufacturers – Partnership for Safe Medicines

22.84

★★★★★5.0 (157)

The expanding benefits of GLP-1 medicines: Cell Reports Medicine

21.23

★★★★★4.7 (84)

📣As of March 19, 2025, tirzepatide may 🚫NO LONGER 🚫 legally be made/distributed/sold by compounding pharmacies. On May 22, 2025 the same will be true of semaglutide. BRAND NAME ONLY is legal (Ozempic,

27.32

★★★★★4.9 (203)

Is Semaglutide Linked to NAION? A Case Report on a Rare Ocular Complication

21.34

★★★★★5.0 (176)

FDA has approved a new oral form of semaglutide for long-term weight reduction in adults with obesity or overweight. The new oral tablet is also indicated for reducing the risk of major

28.14

★★★★★4.8 (132)